Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25th 2022, Krebs Biochemicals & Industries has informed that the Company has approved the application of the shareholder for issue of duplicate share certificate and 'Letter of Confirmation' dated 27-02-2023 has been issued by Registrar and Share Transfer Agent, KFin Technologies to the shareholder in lieu of Duplicate Share Certificates.
The above information is a part of company’s filings submitted to BSE.
